autonomic nervous system disease: A disease involving the autonomic nervous system.
Other and unspecified disorders of autonomic nervous system
DOID EFO Endpoint Browser PheWeb
G6_AUTOTHUNS
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
177 |
4. Check minimum number of eventsNone |
177 |
5. Include endpointsNone |
177 |
6. Filter based on genotype QC (FinnGen only) |
158 |
Control definitions (FinnGen only)
- Control exclude
- G6_AUTONOM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified disorders of autonomic nervous system
based on the number of shared cases.
Similar with more cases:
- Autonomic disorders
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1130 | 550 | 569 |
| Only index persons | 923 | 477 | 446 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 50.73 | 48.91 | 52.18 |
| Only index persons | 48.28 | 47.06 | 49.57 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 158 | 96 | 62 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 49.52 | 46.35 | 54.42 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 164
- Matched controls
- 1640
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G90.8
ICD-10 Finland
Other disorders of autonomic nervous system
+∞
92.7
80
*
G90.9
ICD-10 Finland
Disorder of autonomic nervous system, unspecified
+∞
78.6
69
*
U09.9
ICD-10 Finland
Post COVID-19 condition, unspecified
40.8
26.8
33
10
R53
ICD-10 Finland
Malaise and fatigue
4.4
19.7
81
298
N03AX16
ATC
[U] pregabalin
4.0
16.0
63
219
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.9
15.7
32
65
N06AX21
ATC
duloxetine; oral
4.7
14.9
42
113
R03DC03
ATC
montelukast; oral
4.1
14.7
51
161
C07AB07
ATC
bisoprolol; oral
3.5
14.1
99
495
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.4
12.0
35
96
R55
ICD-10 Finland
Syncope and collapse
4.6
11.9
32
82
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.3
11.4
25
54
G93.3
ICD-10 Finland
Postviral fatigue syndrome
22.0
11.4
16
8
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
6.2
11.0
20
36
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.6
10.9
22
44
R42
ICD-10 Finland
Dizziness and giddiness
3.3
10.7
54
214
3378X
ICD-9 Finland
Disorders of the autonomic nervous system[NEUROPATHIA AUTONOMICA PERIPHERICA ALIA DEFINITA]
+∞
10.5
10
*
R68.88
ICD-10 Finland
Other specified general symptoms and signs, not elsewhere classified.
20.4
10.5
15
8
K59.09
ICD-10 Finland
Constipation, unspecified
5.2
9.6
21
45
H02AA02
ATC
fludrocortisone; oral
105.9
9.5
10
*
N05BA04
ATC
oxazepam; oral
2.9
9.4
62
284
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
8.7
89
505
N03AX12
ATC
[U] gabapentin; oral
3.2
8.6
40
149
N28
ICPC
Limited function/disability (N)
29.3
8.6
11
*
A28
ICPC
Limited function/disability NOS
3.3
8.5
37
132
N06AX16
ATC
venlafaxine; oral
3.2
8.5
41
156
L28
ICPC
Limited function/disability (L)
3.2
8.5
39
144
U09
ICD-10 Finland
Post COVID-19 condition
18.3
8.2
12
7
C07AA05
ATC
propranolol; systemic
2.8
8.2
52
231
XQ800
NOMESCO Finland
Prick test
4.4
8.2
22
56
AA1AD
NOMESCO Finland
CT of head and brain
2.8
8.2
57
266
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.2
8.0
36
131
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.6
8.0
29
92
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
7.8
57
271
G62.8
ICD-10 Finland
Other specified polyneuropathies
83.7
7.5
8
*
A02BC02
ATC
pantoprazole; systemic
2.7
7.4
120
826
L29
ICPC
Musculoskeletal sympt/complt other
3.6
7.3
26
81
G90.0
ICD-10 Finland
Idiopathic peripheral autonomic neuropathy
+∞
7.3
7
*
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.0
7.3
37
144
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.7
7.3
25
76
Z2446
NOMESCO Finland
Social worker
4.2
7.2
20
52
A06AC01
ATC
ispaghula (psylla seeds); oral
2.7
7.2
51
238
H02AB06
ATC
prednisolone; systemic
2.4
7.2
88
530
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
6.2
7.0
18
32
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
3.0
6.8
34
131
N02AX02
ATC
tramadol; systemic, rectal
2.4
6.8
78
453
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
6.8
49
230
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
6.8
30
108
R06.0
ICD-10 Finland
Dyspnoea
2.5
6.7
58
296
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
6.7
78
456
A02BA02
ATC
ranitidine; systemic
2.9
6.7
35
139
N03AE01
ATC
clonazepam; systemic
6.0
6.5
17
31
N06AX26
ATC
vortioxetine; oral
3.6
6.4
22
67
M35.7
ICD-10 Finland
Hypermobility syndrome
11.7
6.4
11
10
A99
ICPC
Disease/condition unspecnature/site
3.1
6.4
29
106
N99
ICPC
Neurological disease other
18.9
6.3
9
5
Z02.7
ICD-10 Finland
Issue of medical certificate
3.6
6.3
22
68
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
6.2
47
225
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
6.2
41
184
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
13.2
6.2
10
8
H02AB07
ATC
prednisone; oral
3.0
6.2
29
108
Z3226
NOMESCO Finland
Physiotherapist
2.7
6.1
39
172
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
7.7
6.1
13
18
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.9
6.0
14
22
UJF30
NOMESCO Finland
Ileoscopy through colon
3.2
6.0
26
92
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
93
420
3.80
16.08
2.8
2.1
95.36
205.48
u/l
2.08
88
407
111
630
3.36
12.16
3.3
2.5
83.21
75.08
nmol/l
1.83
100
581
38
110
4.19
12.14
3.1
2.4
—
28.10
—
0
8
70
323
3.04
10.68
2.6
1.8
0.52
1.28
mg/l
2.77
52
247
100
568
2.95
10.32
6.3
5.1
36.50
36.37
g/l
0.10
92
546
20
40
5.56
9.85
2.5
2.5
24.93
23.79
mmol/l
0.61
20
40
99
572
2.84
9.68
2.6
1.9
101.47
96.97
pmol/l
0.48
58
312
110
685
2.84
9.09
9.9
7.8
1.22
1.21
mmol/l
0.39
99
596
125
835
3.09
9.00
11.9
10.3
3.81
4.05
e9/l
0.71
112
736
21
52
4.48
8.08
1.6
1.6
0.20
0.23
g/l
1.02
21
52
22
60
4.08
7.48
1.8
2.9
6.99
4.91
iu/ml
—
9
11
35
132
3.10
7.32
1.3
1.3
97.48
117.78
u/ml
0.15
15
56
97
612
2.43
7.11
8.5
7.0
1.21
1.22
mmol/l
0.28
91
577
70
383
2.44
7.05
1.8
1.6
20.60
21.11
nmol/l
0.11
64
336
140
1062
3.17
6.82
6.4
4.2
8.51
10.01
mm/h
1.12
133
999
17
41
4.51
6.73
1.6
1.3
—
—
—
0
0
13
16
8.72
6.47
1.2
1.0
—
—
—
0
0
113
783
2.43
6.44
4.8
3.0
123.10
100.78
ug/l
0.20
107
746
70
397
2.33
6.37
1.6
1.3
8.60
1.36
u/ml
0.69
21
110
49
240
2.49
6.16
1.6
1.7
437.76
447.06
pmol/l
0.09
41
208
20
59
3.72
6.09
2.6
1.5
—
—
—
0
0
13
19
7.33
5.86
1.2
1.1
—
—
—
0
0
136
1051
2.72
5.72
9.3
8.0
75.43
76.32
u/l
0.11
129
1005
20
63
3.48
5.53
1.6
1.5
9.35
10.31
u/l
0.12
15
52
45
224
2.39
5.39
3.1
2.7
11.76
2.51
e6/l
0.53
19
101
105
741
2.16
5.23
4.9
6.2
11.41
12.72
umol/l
0.24
98
703
25
94
2.96
5.20
1.0
1.0
—
—
—
0
0
68
410
2.13
5.09
4.7
2.8
0.17
0.37
e6/l
1.12
43
300
22
78
3.10
5.05
2.8
3.8
1.84
1.25
mmol/l
0.27
16
57
11
18
6.47
4.69
1.2
1.1
—
—
—
0
0
139
1124
2.55
4.64
6.0
4.4
14.95
14.57
pmol/l
1.23
134
1047
46
246
2.21
4.60
2.1
2.6
2.42
2.43
mmol/l
0.13
40
223
20
71
3.07
4.58
4.1
3.2
25.09
24.04
mmol/l
0.89
20
71
19
66
3.12
4.50
1.3
1.9
5.37
3.60
mg/l
0.21
12
50
68
435
1.96
4.16
5.3
3.0
0.15
0.01
estimate
0.45
20
142
8
11
7.58
3.90
1.0
1.0
—
—
—
0
0
44
248
2.06
3.79
3.4
2.6
0.57
0.92
e6/l
0.83
18
124
108
823
1.91
3.75
7.0
5.3
6.79
6.47
mmol/l
0.62
102
763
26
119
2.41
3.68
1.6
1.5
24.39
25.07
iu/l
0.04
20
103
29
140
2.30
3.65
2.5
2.9
28.79
29.24
u/l
0.05
24
115
56
348
1.93
3.65
3.2
2.7
319.66
335.66
umol/l
0.52
47
316
70
469
1.86
3.61
4.0
3.4
2.34
2.35
mmol/l
0.45
62
437
35
184
2.15
3.60
2.0
1.6
1156.10
1165.08
nmol/l
0.02
26
141
72
488
1.85
3.57
4.8
3.6
14.58
40.28
ng/l
2.29
37
319
102
770
1.86
3.57
5.5
3.6
0.00
9.61
estimate
0.50
27
169
47
279
1.96
3.48
1.5
1.3
4.33
9.67
u/ml
0.81
18
115
56
353
1.89
3.47
3.8
3.2
549.54
1069.60
ng/l
2.14
48
290
101
765
1.83
3.45
5.5
3.6
0.00
0.00
estimate
-0.00
27
167
42
242
1.99
3.38
5.3
2.9
243.84
146.91
ng/l
0.16
25
160
9
19
4.95
3.29
1.4
1.5
0.36
0.46
nmol/l
—
9
19
15
55
2.90
3.25
2.5
2.4
157.20
186.45
%
0.53
15
55
80
574
1.77
3.20
5.1
3.4
0.17
0.00
estimate
0.48
24
143
37
208
2.01
3.17
2.2
1.9
—
—
—
0
0
101
777
1.78
3.15
5.5
3.7
0.00
0.00
estimate
-0.00
25
155
58
383
1.80
3.04
2.9
1.9
2.48
2.71
mg/l
0.44
50
332
12
37
3.42
3.00
2.3
3.9
9.53
8.69
kpa
0.56
12
37
9
22
4.26
2.93
2.4
3.1
17.90
15.75
%
—
9
22
6
9
6.87
2.89
1.8
1.1
—
—
—
0
0
16
66
2.58
2.81
2.3
1.8
—
—
—
0
0
5
6
8.54
2.77
2.4
2.8
119.40
157.33
%
—
5
6
12
40
3.15
2.76
1.1
1.2
2.28
1.87
u/ml
—
7
22
6
10
6.18
2.72
1.8
1.2
—
—
—
0
0
32
182
1.94
2.64
2.3
3.1
8.26
5.69
umol/l
0.26
27
156
11
36
3.20
2.62
5.4
3.8
3.19
2.76
ratio
—
6
20
149
1328
2.33
2.60
8.0
5.3
2.15
1.80
mu/l
0.33
141
1243
8
20
4.15
2.60
1.0
1.7
—
—
—
0
0
28
153
2.00
2.58
2.3
1.7
—
—
—
0
0
10
31
3.37
2.56
1.0
1.1
—
—
—
0
0
35
209
1.86
2.50
1.1
1.9
1.52
1.40
%
0.39
30
184
58
402
1.69
2.49
5.4
4.2
19.35
10.63
mg/mmol
0.28
38
258
5
8
6.40
2.39
1.2
1.0
0.29
0.30
g/l
—
5
8
47
312
1.71
2.35
1.5
1.3
77.23
27.27
iu/ml
0.73
14
99
149
1340
2.22
2.34
19.4
13.3
89.64
87.24
ml/min/173m2
0.63
139
1228
26
144
1.96
2.31
2.4
1.8
—
—
—
0
0
11
41
2.80
2.25
1.6
1.5
0.45
0.28
nmol/l
0.33
11
33
5
9
5.69
2.23
1.4
1.8
—
—
—
0
0
5
9
5.69
2.23
1.0
1.0
—
—
—
0
0
6
14
4.40
2.17
1.3
3.8
1.73
1.42
nmol/l
—
6
14
19
96
2.11
2.16
6.3
6.4
25.20
24.65
mmol/l
0.42
19
96
24
133
1.94
2.13
9.5
11.8
1.38
1.22
mmol/l
0.12
18
111
8
25
3.31
2.12
1.0
1.8
—
—
—
0
0
5
10
5.12
2.08
1.4
3.6
347.40
920.00
u/ml
—
5
10
7
21
3.43
1.99
3.1
1.2
—
—
—
0
0
5
11
4.65
1.95
1.4
1.3
—
—
—
0
0
5
12
4.26
1.83
2.0
2.6
—
—
—
0
0
7
23
3.13
1.82
4.1
2.7
5.17
10.23
pmol/l
—
7
23
8
29
2.85
1.81
1.1
1.7
—
—
—
0
0
7
24
3.00
1.74
1.0
1.7
—
—
—
0
0
5
13
3.93
1.73
1.4
1.2
—
—
—
0
0
153
1423
2.12
1.64
25.4
14.0
17.26
21.61
mg/l
1.37
125
1141
55
414
1.49
1.57
4.3
3.7
0.00
0.00
estimate
-0.00
25
157
7
28
2.56
1.47
2.3
1.5
—
—
—
0
0
7
29
2.48
1.41
2.0
2.8
140.00
126.20
g/l
—
7
20
6
23
2.67
1.38
1.5
1.1
—
—
—
0
0
6
23
2.67
1.38
1.5
1.1
—
—
—
0
0
16
91
1.84
1.34
1.8
1.6
—
—
—
0
0
118
1048
1.45
1.31
3.6
3.2
49.74
43.20
u/l
0.21
112
1005
143
1324
1.63
1.26
4.9
4.6
6.07
5.80
mmol/l
0.75
135
1233
138
1269
1.55
1.24
6.8
5.6
39.18
38.33
mmol/mol
0.46
130
1206
5
19
2.68
1.22
1.2
1.2
—
—
—
0
0
10
50
2.06
1.19
1.4
1.1
—
—
—
0
0
42
326
1.39
0.99
4.2
3.6
1.02
1.02
kg/l
0.04
27
206
9
50
1.85
0.98
1.2
1.1
—
—
—
0
0
43
339
1.36
0.92
1.7
2.2
—
—
—
0
0
40
312
1.37
0.92
1.4
1.5
—
—
—
0
0
11
64
1.77
0.88
1.1
1.3
—
—
—
0
0
20
140
1.49
0.81
2.3
2.0
—
—
—
0
0
34
266
1.35
0.77
3.1
2.2
—
—
—
0
0
23
168
1.43
0.77
2.4
2.1
—
—
—
0
0
70
611
1.25
0.70
2.2
1.9
1.65
1.41
mmol/l
0.80
58
526
7
42
1.70
0.69
1.0
1.7
—
—
—
0
0
36
292
1.30
0.64
3.2
2.3
—
—
—
0
0
11
71
1.59
0.64
4.2
2.5
0.48
0.65
%
1.40
11
71
11
72
1.57
0.61
1.5
1.4
—
—
—
0
0
6
35
1.74
0.58
1.0
1.4
—
—
—
0
0
11
73
1.54
0.58
4.2
2.5
0.79
1.24
%
2.08
11
73
6
39
1.56
0.53
1.5
1.6
—
—
—
0
0
6
39
1.56
0.53
1.0
1.7
—
—
—
0
0
6
40
1.52
0.52
1.2
1.2
—
—
—
0
0
15
197
0.74
0.47
1.7
2.0
3.25
3.47
ratio
—
10
155
17
131
1.33
0.44
2.4
3.1
—
—
—
0
0
43
374
1.20
0.43
1.5
1.7
—
—
—
0
0
0
15
0.00
0.41
0.0
3.8
—
85.20
—
0
15
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
111
1057
1.16
0.34
5.1
3.6
—
—
—
0
0
8
62
1.30
0.28
1.4
1.5
—
—
—
0
0
141
1377
1.17
0.24
5.4
4.7
4.73
4.65
mmol/l
0.39
134
1301
33
296
1.14
0.23
4.8
4.5
21.87
23.27
%
0.20
14
143
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
6
49
1.23
0.20
2.5
1.8
—
—
—
0
0
6
49
1.23
0.20
2.5
2.2
—
—
—
0
0
140
1376
1.12
0.15
5.4
4.6
1.43
1.46
mmol/l
0.41
132
1290
141
1390
1.10
0.12
6.1
5.2
2.86
2.73
mmol/l
0.91
135
1309
11
95
1.17
0.12
2.7
1.4
—
—
—
0
0
5
44
1.14
0.10
1.8
2.5
—
—
—
0
0
11
97
1.14
0.09
2.2
2.9
66.20
70.88
ml/min/173m2
—
5
40
6
71
0.84
0.08
1.2
1.0
1.59
1.59
g/l
—
6
71
6
74
0.80
0.07
1.2
1.1
1.02
0.85
g/l
—
6
74
133
1315
1.06
0.07
4.6
3.9
1.43
1.26
mmol/l
1.22
125
1222
15
139
1.09
0.05
8.8
6.6
—
—
—
0
0
67
684
0.97
0.05
2.6
2.8
—
—
estimate
—
0
0
13
120
1.09
0.05
1.8
1.3
—
—
—
0
0
22
228
0.96
0.02
3.7
3.1
0.65
0.77
ug/l
0.48
15
150
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
41.98
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.6
—
4.56
—
0
7
0
5
0.00
-0.00
0.0
8.4
—
—
—
0
0
156
1553
1.09
-0.00
37.3
22.1
135.44
135.70
g/l
0.08
156
1536
5
54
0.92
-0.00
1.0
2.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
1.80
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.6
—
11.19
—
0
7
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.7
—
15.40
—
0
7
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
12.11
—
0
9
Mortality – FinRegistry
↥Association
Association between endpoint G6_AUTOTHUNS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_AUTOTHUNS | 2.676 [1.8, 3.98] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.258 |
During the follow-up period (1.1.1998 — 31.12.2019), 87 out of 362 females with G6_AUTOTHUNS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_AUTOTHUNS | 2.681 [2.0, 3.6] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 159 out of 402 males with G6_AUTOTHUNS died.
Mortality risk
Mortality risk for people of age
years, who have G6_AUTOTHUNS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.252% | 0.419% |
| 5 | 1.563% | 3.014% |
| 10 | 3.867% | 7.291% |
| 15 | 7.165% | 13.851% |
| 20 | 12.414% | 22.741% |
Relationships between endpoints
↥Index endpoint: G6_AUTOTHUNS – Other and unspecified disorders of autonomic nervous system
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data